Stress-induced cleavage of Myc promotes cancer cell survival

Genes and Development

Volumn 28, Issue 7, 2014, Pages 689-707

  Conacci Sorrell, Maralice ^a   Ngouenet, Celine ^a   Anderson, Sarah ^a   Brabletz, Thomas ^b   Eisenman, Robert N ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Autophagy; Fascin; Hypoxia; Motility; Myc; Myc nick

Indexed keywords

ALPHA TUBULIN; CALPAIN; CISPLATIN; CYTOPLASM PROTEIN; ETOPOSIDE; IMATINIB; MYC PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL DEATH; CELL DIVISION; CELL LINE; CELL MOTILITY; CELL STRESS; CELL SURVIVAL; COLON CANCER; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; MULTIPLE CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

AUTOPHAGY; FASCIN; HYPOXIA; MOTILITY; MYC; MYC-NICK;

ACETYLATION; ANIMALS; ANTINEOPLASTIC AGENTS; AUTOPHAGY; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; CYTOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC INSTABILITY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-MYC; STRESS, PHYSIOLOGICAL;

EID: 84898838516     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.231894.113     Document Type: Article

References (79)

1. Adams J. M, Cory S. 1985. Myc oncogene activation in B and T lymphoid tumours. Proc R Soc Lond B Biol Sci 226: 59-72.
2. Aratyn Y. S, Schaus TE, Taylor EW, Borisy GG. 2007. Intrinsic dynamic behavior of fascin in filopodia. Mol Biol Cell 18: 3928-3940.
3. Bai M. K, Costopoulos JS, Christoforidou BP, Papadimitriou CS. 1994. Immunohistochemical detection of the c-myc oncogene product in normal, hyperplastic and carcinomatous endometrium. Oncology 51: 314-319.
4. Barcellos K. S, Bigarella CL, Wagner MV, Vieira KP, Lazarini M, Langford P. R, Machado-Neto JA, Call SG, Staley DM, Chung JY, et al. 2013. ARHGAP21 protein, a new partner of α-tubulin involved in cell-cell adhesion formation and essential for epithelial-mesenchymal transition. J Biol Chem 288: 2179-2189.
5. Brabletz T., Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T. 2001. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci 98: 10356-10361.
6. Calcagno D. Q, Guimaraes AC, Leal MF, Seabra AD, Khayat AS, Pontes TB, Assumpcao PP, De Arruda Cardoso Smith M, Burbano RR. 2009. MYC insertions in diffuse-type gastric adenocarcinoma. Anticancer Res 29: 2479-2483.
7. Conacci-Sorrell M, Eisenman RN. 2011. Post-translational control of Myc function during differentiation. Cell Cycle 10: 604-610.
8. Conacci-Sorrell M, Ngouenet C, Eisenman RN. 2010. Myc-nick: a cytoplasmic cleavage product of Myc that promotes α-tubulin acetylation and cell differentiation. Cell 142: 480-493.
9. Dalerba P., Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A., Huang EH, Simeone DM, et al. 2007. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci 104: 10158-10163.
10. Dang C.V. 2010. Glutaminolysis: supplying carbon or nitrogen or both for cancer cells? Cell Cycle 9: 3884-3886.
11. Dang C.V. 2011. Enigmatic MYC conducts an unfolding systems biology symphony. Genes Cancer 1: 526-531.
12. Dang C.V. 2012. MYC on the path to cancer. Cell 149: 22-35.
13. Dang C.V. 2013. MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med 3: a014217.
14. Dey S., Tameire F, Koumenis C. 2013. PERK-ing up autophagy during MYC-induced tumorigenesis. Autophagy 9: 612-614.
15. Eilers M., Eisenman RN. 2008. Myc's broad reach. Genes Dev 22: 2755-2766.
16. Evan G. I, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M., Waters CM, Penn LZ, Hancock DC. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
17. Frank S. R, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM, Livingston D. M, Amati B. 2003. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 4: 575-580.
18. Freedman V. H, Shin SI. 1974. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3: 355-359.
19. Geeraert C., Ratier A, Pfisterer SG, Perdiz D, Cantaloube I, Rouault A., Pattingre S, Proikas-Cezanne T, Codogno P, Pous C. 2010. Starvation-induced hyperacetylation of tubulin is required for the stimulation of autophagy by nutrient deprivation. J Biol Chem 285: 24184-24194.
20. Goode B. L, Drubin DG, Barnes G. 2000. Functional cooperation between the microtubule and actin cytoskeletons. Curr Opin Cell Biol 12: 63-71.
21. Guccione E., Martinato F, Finocchiaro G, Luzi L, Tizzoni L, Dall'Olio V, Zardo G, Nervi C, Bernard L, Amati B. 2006. Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 8: 764-770.
22. Hanahan D., Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144: 646-674.
23. Hatton B. A, Knoepfler PS, Kenney AM, Rowitch DH, de Alboran IM, Olson JM, Eisenman RN. 2006. N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth. Cancer Res 66: 8655-8661.
24. He C., Klionsky DJ. 2009. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43: 67-93.
25. He T. C, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin P. J, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
26. Hermeking H., Funk JO, Reichert M, Ellwart JW, Eick D. 1995. Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21WAF1/CIP1/SDI1. Oncogene 11: 1409-1415.
27. Hockel M., Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. 1996. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56: 4509-4515.
28. Hongo K., Tsuno NH, Kawai K, Sasaki K, Kaneko M, Hiyoshi M, Murono K., Tada N, Nirei T, Sunami E, et al. 2013. Hypoxia enhances colon cancer migration and invasion through promotion of epithelial-mesenchymal transition. J Surg Res 182: 75-84.
29. Ji H., Wu G, Zhan X, Nolan A, Koh C, De Marzo A, Doan HM, Fan J., Cheadle C, Fallahi M, et al. 2011. Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation. PLoS ONE 6: e26057.
30. Jubb A. M, Buffa FM, Harris AL. 2009. Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis. J Cell Mol Med 14: 18-29.
31. Jung A., Schrauder M, Oswald U, Knoll C, Sellberg P, Palmqvist R, Niedobitek G, Brabletz T, Kirchner T. 2001. The invasion front of human colorectal adenocarcinomas shows colocalization of nuclear β-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol 159: 1613-1617.
32. Kahlert C., Lahes S, Radhakrishnan P, Dutta S, Mogler C, Herpel E, Brand K, Steinert G, Schneider M, Mollenhauer M, et al. 2011. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro. Clin Cancer Res 17: 7654-7663.
33. Keith B., Johnson RS, Simon MC. 2011. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 12: 9-22.
34. Kim J. W, Zeller KI, Wang Y, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV. 2004. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol Cell Biol 24: 5923-5936.
35. Knoepfler P. S, Zhang XY, Cheng PF, Gafken PR, McMahon SB, Eisenman R.N. 2006. Myc influences global chromatin structure. EMBO J 25: 2723-2734.
36. Kodama A., Lechler T, Fuchs E. 2004. Coordinating cytoskeletal tracks to polarize cellular movements. J Cell Biol 167: 203-207.
37. Li Q., Kluz T, Sun H, Costa M. 2009. Mechanisms of c-myc degradation by nickel compounds and hypoxia. PLoS ONE 4: e8531.
38. Li A., Dawson JC, Forero-Vargas M, Spence HJ, Yu X, Konig I, Anderson K., Machesky LM. 2010. The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion. Curr Biol 20: 339-345.
39. Li H., Nepal RM, Martin A, Berger SA. 2012. Induction of apoptosis in Emu-myc lymphoma cells in vitro and in vivo through calpain inhibition. Exp Hematol 40: 548-563. e2.
40. Machesky L. M, Li A. 2010. Fascin: invasive filopodia promoting metastasis. Commun Integr Biol 3: 263-270.
41. McMahon SB, Wood MA, Cole MD. 2000. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol Cell Biol 20: 556-562.
42. Mucaj V., Shay JE, Simon MC. 2012. Effects of hypoxia and HIFs on cancer metabolism. Int J Hematol 95: 464-470.
43. Nagy P., Varga A, Pircs K, Hegedus K, Juhasz G. 2013. Myc-driven overgrowth requires unfolded protein response-mediated induction of autophagy and antioxidant responses in Drosophila melanogaster. PLoS Genet 9: e1003664.
44. Nie Z., Hu G, Wei G, Cui K, Yamane A, ReschW, Wang R, Green DR, Tessarollo L, Casellas R, et al. 2012. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151: 68-79.
45. Orian A., van Steensel B, Delrow J, Bussemaker HJ, Li L, Sawado T, Williams E, Loo LW, Cowley SM, Yost C, et al. 2003. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev 17: 1101-1114.
46. Ozerhan I. H, Ersoz N, Onguru O, Ozturk M, Kurt B, Cetiner S. 2010. Fascin expression in colorectal carcinomas. Clinics 65: 157-164.
47. Pietilainen T., Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjanen K. 1995. Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival. Anticancer Res 15: 959-964.
48. Rahl P. B, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, Sharp P. A, Young RA. 2010. c-Myc regulates transcriptional pause release. Cell 141: 432-445.
49. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C., De Maria R. 2007. Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
50. Rodriguez Fernandez JL, Geiger B, Salomon D, Ben-Ze'ev A. 1993. Suppression of vinculin expression by antisense transfection confers changes in cell morphology, motility, and anchorage-dependent growth of 3T3 cells. J Cell Biol 122: 1285-1294.
51. Ruzinova M. B, Caron T, Rodig SJ. 2010. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation. Am J Surg Pathol 34: 882-891.
52. Saggar J. K, Yu M, Tan Q, Tannock IF. 2013. The tumor microenvironment and strategies to improve drug distribution. Front Oncol 3: 154.
53. Sansom O. J, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR, Vass JK, Athineos D, Clevers H, Clarke AR. 2007. Myc deletion rescues Apc deficiency in the small intestine. Nature 446: 676-679.
54. Sato K., Tsuchihara K, Fujii S, Sugiyama M, Goya T, Atomi Y, Ueno T., Ochiai A, Esumi H. 2007. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res 67: 9677-9684.
55. Schober J. M, Komarova YA, Chaga OY, Akhmanova A, Borisy GG. 2007. Microtubule-targeting-dependent reorganization of filopodia. J Cell Sci 120: 1235-1244.
56. Shim H., Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla-Favera R, Dang CV. 1997. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci 94: 6658-6663.
57. Shim H., Chun YS, Lewis BC, Dang CV. 1998. A unique glucosedependent apoptotic pathway induced by c-Myc. Proc Natl Acad Sci 95: 1511-1516.
58. Shortt J., Johnstone RW. 2012. Oncogenes in cell survival and cell death. Cold Spring Harb Perspect Biol4: a009829.
59. Sloan E. J, Ayer DE. 2010. Myc, mondo, and metabolism. Genes Cancer 1: 587-596.
60. Storr S. J, Carragher NO, Frame MC, Parr T, Martin SG. 2011. The calpain system and cancer. Nat Rev Cancer 11: 364-374.
61. Sui X., Chen R, Wang Z, Huang Z, Kong N, Zhang M, Han W, Lou F., Yang J, Zhang Q, et al. 2013. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis 4: e838.
62. Toh P. P, Luo S, Menzies FM, Rasko T, Wanker EE, Rubinsztein DC. 2013. Myc inhibition impairs autophagosome formation. Hum Mol Genet 22: 5237-5248.
63. Tredan O., Galmarini CM, Patel K, Tannock IF. 2007. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 99: 1441-1454.
64. Vander Heiden MG, Locasale JW, Swanson KD, Sharfi H, Heffron G. J, Amador-Noguez D, Christofk HR, Wagner G, Rabinowitz J. D, Asara JM, et al. 2010. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329: 1492-1499.
65. Vignjevic D., Kojima S, Aratyn Y, Danciu O, Svitkina T, Borisy GG. 2006. Role of fascin in filopodial protrusion. J Cell Biol 174: 863-875.
66. Vignjevic D., Schoumacher M, Gavert N, Janssen KP, Jih G, Lae M, Louvard D, Ben-Ze'ev A, Robine S. 2007. Fascin, a novel target of β-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 67: 6844-6853.
67. Vinci M., Gowan S, Boxall F, Patterson L, Zimmermann M, Court W., Lomas C, Mendiola M, Hardisson D, Eccles SA. 2011. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol 10: 29.
68. Wagner A. J, Kokontis JM, Hay N. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev 8: 2817-2830.
69. Wolf E., Gebhardt A, Kawauchi D, Walz S, von Eyss B, Wagner N, Renninger C., Krohne G, Asan E, Roussel MF et al. 2013. Miz1 is required to maintain autophagic flux. Nat Commun 4: 2535.
70. Wong W. J, Qiu B, Nakazawa MS, Qing G, Simon MC. 2013. MYC degradation under low O2 tension promotes survival by evading hypoxia-induced cell death. Mol Cell Biol 33: 3494-3504.
71. Xie R., Nguyen S, McKeehan WL, Liu L. 2010. Acetylated microtubules are required for fusion of autophagosomes with lysosomes. BMC Cell Biol 11: 89.
72. Xu W., Li Y, Liu C, Zhao S. 2013. Protein lysine acetylation guards metabolic homeostasis to fight against cancer. Oncogene. doi: 10.10388/onc.2013.163.
73. Yang Z. J, Chee CE, Huang S, Sinicrope FA. 2011. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 10: 1533-1541.
74. Yang F. C, Tan BC, Chen WH, Lin YH, Huang JY, Chang HY, Sun HY, Hsu PH, Liou GG, Shen J, et al. 2013a. Reversible acetylation regulates salt-inducible kinase (SIK2) and its function in autophagy. J Biol Chem 288: 6227-6237.
75. Yang Y., Fiskus W, Yong B, Atadja P, Takahashi Y, Pandita TK, Wang H. G, Bhalla KN. 2013b. Acetylated hsp70 and KAP1-mediated Vps34 SUMOylation is required for autophagosome creation in autophagy. Proc Natl Acad Sci 110: 6841-6846.
76. Yi C., Ma M, Ran L, Zheng J, Tong J, Zhu J, Ma C, Sun Y, Zhang S., Feng W, et al. 2012. Function and molecular mechanism of acetylation in autophagy regulation. Science 336: 474-477.
77. Yuneva M., Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. 2007. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol 178: 93-105.
78. Zanet J., Jayo A, Plaza S, Millard T, Parsons M, Stramer B. 2012. Fascin promotes filopodia formation independent of its role in actin bundling. J Cell Biol 197: 477-486.
79. Zindy F., Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 12: 2424-2433.